Healthcare Global Therapeutic Vaccines Market | Page 2

The global therapeutic vaccines market is segmented into vaccine type such as
infectious disease vaccines, addiction vaccines, neurological disease vaccines and
autoimmune disease vaccines. Among these segments, infectious disease vaccines
segment is expected to witness satisfactory growth over the forecast period. The
growth of the infectious disease vaccines segment can be attributed to increasing
prevalence of infectious diseases such as HIV and other infectious diseases.
Moreover, it is used to provide immunity in human body to fight various
infectious diseases.
Global therapeutic vaccines market is expected to register a 33.8% CAGR over the
forecast period. Moreover, the global therapeutic vaccines market is expected to
reach at revenue of around USD 4.8 Billion by the end of 2021. The market is
expected to expand on the back of increasing prevalence of infectious diseases
such as HIV, Cancer, hepatitis C, neurological diseases and others across the
globe. Moreover, increasing geriatric population is also a key factor which is
fuelling the demand for therapeutic vaccines.
The Asia Pacific region is likely to be fastest growing segment during the forecast
period. Improving healthcare infrastructure, rising geriatric population and
increased spending on R&D activities in healthcare sector are few of the key
factors which are envisioned to drive the growth of therapeutic vaccine market in
Asia Pacific region.
Increase in Incidence of Cancer
Cancer is one of the leading causes of deaths and was responsible for more than 8
million deaths in 2015, (according to WHO). During treatment of cancer,
therapeutic vaccines are one of the most important drugs/vaccines which are
provided to the patients to stimulate the immune system to target an infection.
Further, growing use of therapeutic vaccines in cancer treatment is expected to
propel the growth of market over the forecast period.
Request For Sample Pages: https://www.researchnester.com/sample-
request/2/rep-id-108
Favourable governmen1t initiatives and programmes
Government initiatives and encouragement in various economies regarding
development of therapeutic vaccine are further opening the opportunities for the
various therapeutic vaccines manufacturers. Moreover, increasing prevalence of
Copyright © Research Nester
www.researchnester.com